NCT06648525 2024-10-18Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICCHarbin Medical UniversityPhase 2 Not yet recruiting68 enrolled